Gri Bio Inc (GRI) Stock Price, Quote & News

Company Profile

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a no...

Industry: Biotechnology

Sector: Healthcare

Phone: 619 400 1170

Website: www.gribio.com

Address:

2223 Avenida de la Playa, Suite 208, La Jolla, United States

Cocky_day_trader Jan. 30 at 4:58 AM

$GRI No bro You aren't trading or investing. You are purely gambling on hope. Before entering trade: Are they compliant Are they cashed Are they backed by inst Then think of set ups I ignore that because i have the skills but you dont bro. Stick with s&p, vanguard, etf and indicies. Oh by the way did you know that h.c. Wainwrights reputation is always scrutinized? And finally my followers always make bank

0 · Reply

gregwiseman Jan. 30 at 2:58 AM

$GRI i m here only for trading not investing , this is not my place i should invest big money, investing in small bios is just only kind of gambling not an investment , i cannot invest my money to something and 2 days later i see my money wiped away , its not kind of investment i like its kind of gamble. if i want to burn out my money i prefer to go in cassinos or las vegas but i dont have extra money to burn .

0 · Reply

Chromaticity Jan. 30 at 2:19 AM

$GRI it seems ATM injection is not over yet.

1 · Reply

Cocky_day_trader Jan. 30 at 12:01 AM

$GRI Why Google saya this of H. C. Wainwright?

0 · Reply

drweinerdog1 Jan. 29 at 10:29 PM

$GRI how are these types of stocks allowed to be on the exchange

1 · Reply

Bionco Jan. 29 at 9:36 PM

$GRI I will place a small bet on this stock and will be gradually accumulating shares until the company presents the full set of data at a major medical conference. I am hopeful for the presentation happening in the first half of this year .... Let's see......

0 · Reply

Cocky_day_trader Jan. 29 at 9:12 PM

$GRI I am coming end of the day to congratulate myself. Spoke with authority and confidence and: I was right Pumpers were wrong We don't know though how many more ATM will hit supply!

0 · Reply

Cocky_day_trader Jan. 29 at 8:59 PM

$GRI I saved alot of people from pumpers who want to dump ATM at $11 If anyone wants to buy now its their discretion but back then i saved them. Well whoever listened is saved, whoever didn't holding at $11 waiting for a miracle $BINI are loughing at you

3 · Reply

Cocky_day_trader Jan. 29 at 8:51 PM

$GRI

0 · Reply

GTMStox Jan. 29 at 8:50 PM

$GRI This stock is essentially worthless

0 · Reply

GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF

Jan 21, 2026, 4:01 PM EST - 8 days ago

GRI Bio Announces Reverse Stock Split

Dec 12, 2025, 4:05 PM EST - 6 weeks ago

GRI Bio Announces Closing of $8.0 Million Public Offering

Dec 11, 2025, 9:15 AM EST - 7 weeks ago

GRI Bio Announces Pricing of $8,000,000 Million Public Offering

Dec 10, 2025, 4:05 PM EST - 7 weeks ago

GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

Sep 11, 2025, 8:45 AM EDT - 5 months ago

GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

Aug 14, 2025, 9:15 AM EDT - 6 months ago

GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Jul 31, 2025, 1:50 PM EDT - 6 months ago

GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment

Jul 22, 2025, 8:45 AM EDT - 6 months ago

GRI Bio Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 1, 2025, 8:45 AM EDT - 7 months ago

GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)

Jun 26, 2025, 8:00 AM EDT - 7 months ago

GRI Bio's GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

May 21, 2025, 9:15 AM EDT - 9 months ago

GRI Bio to Participate in the Virtual Investor Closing Bell Series

May 16, 2025, 9:15 AM EDT - 9 months ago

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

May 15, 2025, 8:35 AM EDT - 9 months ago

GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025

May 8, 2025, 8:45 AM EDT - 9 months ago

GRI Bio's Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

May 7, 2025, 9:15 AM EDT - 9 months ago

GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

Apr 16, 2025, 8:35 AM EDT - 10 months ago

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference

Apr 2, 2025, 4:05 PM EDT - 10 months ago

GRI Bio Announces Closing of $5.0 Million Public Offering

Apr 1, 2025, 11:15 AM EDT - 10 months ago

GRI Bio Announces Pricing of $5.0 Million Public Offering

Apr 1, 2025, 11:07 AM EDT - 10 months ago

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?

Mar 31, 2025, 8:00 AM EDT - 10 months ago

GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan

Mar 18, 2025, 9:05 AM EDT - 11 months ago

GRI Bio Participates in a Virtual Investor CEO Connect Segment

Mar 17, 2025, 8:05 AM EDT - 11 months ago

GRI Bio Reports Full Year 2024 Financial Results and Reiterates Expected Clinical Data Readouts in 2025 for Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

Mar 11, 2025, 8:35 AM EDT - 11 months ago

GRI Bio Regains Compliance with Nasdaq's Minimum Bid Price Rule

Feb 19, 2025, 9:00 AM EST - 1 year ago

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

Dec 23, 2024, 9:00 AM EST - 1 year ago

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds

Nov 21, 2024, 8:45 AM EST - 1 year ago

GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)

Nov 14, 2024, 4:20 PM EST - 1 year ago

GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis

Oct 24, 2024, 8:30 AM EDT - 1 year ago

GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024

Oct 21, 2024, 5:35 PM EDT - 1 year ago

GRI Bio Announces Exercise of Warrants

Oct 16, 2024, 8:45 AM EDT - 1 year ago

GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621's Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)

Sep 30, 2024, 8:30 AM EDT - 1 year ago

GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions

Sep 25, 2024, 8:45 AM EDT - 1 year ago

GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment

Sep 5, 2024, 8:45 AM EDT - 1 year ago

GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:45 AM EDT - 1 year ago

GRI Bio to Present at the 2024 European Respiratory Congress

Aug 14, 2024, 8:05 AM EDT - 1 year ago

GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Jul 15, 2024, 9:05 AM EDT - 1 year ago

GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series

Jul 11, 2024, 9:20 AM EDT - 1 year ago

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment

Jul 8, 2024, 9:05 AM EDT - 1 year ago

GRI Bio Regains Compliance with Nasdaq

Jul 2, 2024, 9:05 AM EDT - 1 year ago

GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine

Jul 1, 2024, 8:45 AM EDT - 1 year ago

GRI Bio to Present at the 8th Annual IPF Summit

Jun 28, 2024, 4:05 PM EDT - 1 year ago

GRI Bio Announces Closing of $4.0 Million Public Offering

Jun 27, 2024, 9:00 AM EDT - 1 year ago

GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators

May 22, 2024, 9:15 AM EDT - 1 year ago

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs

May 21, 2024, 8:35 AM EDT - 1 year ago

GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)

May 20, 2024, 8:45 AM EDT - 1 year ago

GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)

May 14, 2024, 9:05 AM EDT - 1 year ago

GRI Bio to Present at Alliance Global Partner's 2024 Healthcare Company Showcase

May 13, 2024, 8:00 AM EDT - 1 year ago

GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Apr 29, 2024, 8:45 AM EDT - 1 year ago

GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity

Apr 25, 2024, 9:15 AM EDT - 1 year ago

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Cocky_day_trader Jan. 30 at 4:58 AM

0 · Reply

gregwiseman Jan. 30 at 2:58 AM

0 · Reply

Chromaticity Jan. 30 at 2:19 AM

$GRI it seems ATM injection is not over yet.

1 · Reply

Cocky_day_trader Jan. 30 at 12:01 AM

$GRI Why Google saya this of H. C. Wainwright?

0 · Reply

drweinerdog1 Jan. 29 at 10:29 PM

$GRI how are these types of stocks allowed to be on the exchange

1 · Reply

Bionco Jan. 29 at 9:36 PM

0 · Reply

Cocky_day_trader Jan. 29 at 9:12 PM

$GRI I am coming end of the day to congratulate myself. Spoke with authority and confidence and: I was right Pumpers were wrong We don't know though how many more ATM will hit supply!

0 · Reply

Cocky_day_trader Jan. 29 at 8:59 PM

3 · Reply

Cocky_day_trader Jan. 29 at 8:51 PM

$GRI

0 · Reply

GTMStox Jan. 29 at 8:50 PM

$GRI This stock is essentially worthless

0 · Reply

Cocky_day_trader Jan. 29 at 8:45 PM

$GRI Hahahahahaha Salty pumper crying 😢 Any names you call me doesn't change sec fillings, dilution history, riverse splits machine Ask h.c. Wainwright

1 · Reply

Cocky_day_trader Jan. 29 at 8:10 PM

$GRI Read boy Shorts can buy ATM and cover with them

1 · Reply

FatFingerFreddy Jan. 29 at 7:39 PM

$GRI the only shares available to buy are borrowed, or from shareholders falling for the BS.....shorts cant cover if you dont sell, and they have to

0 · Reply

gregwiseman Jan. 29 at 7:27 PM

$GRI who ever invested in this scam garbage in the last 3 months alreay lost all his money . - 47% only in last 2 days .

1 · Reply

totti09 Jan. 29 at 6:57 PM

$GRI they fuckme too

0 · Reply

loopdjhe Jan. 29 at 6:56 PM

$GRI Hi! Official bag holder since yesterday 🙋‍♂️ Fingers crossed... (my entry was 5.30 🤦‍♂️)

1 · Reply

Chromaticity Jan. 29 at 6:01 PM

$GRI stuck here. Me a bag holder really doubt its OS is only 0.5M.

1 · Reply

Cocky_day_trader Jan. 29 at 5:43 PM

$GRI are you sure float is small again?

1 · Reply

Cocky_day_trader Jan. 29 at 5:42 PM

$GRI ATM to raise $7M is real bro

0 · Reply

Cocky_day_trader Jan. 29 at 5:42 PM

$GRI

1 · Reply

Cocky_day_trader Jan. 29 at 5:41 PM

$GRI Lol thats stupid to think Shorts would do it easily knowing they'll buy the ATM H.C. Wainwright coordinating the ATM and you say buy dips. Shorting tops and cover with ATM seems ok I don't short at all by the way

0 · Reply

TruthTooPower Jan. 29 at 5:34 PM

$GRI!!! Would Not Want To Be Short. When This Mother Wakes Up, When This Market Turns Back With a Float of 487k, it Will MELT UP!!!

2 · Reply

Market Cap	2.05M
Revenue (ttm)	0.00
Net Income (ttm)	-8.21M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	547,800
Avg Vol	382,290
Day's Range	N/A - N/A
Shares Out	497,000.00
Stochastic %K	4%
Beta	-1.39
Analysts	Sell
Price Target	$644.26